Evommune Ownership & Insider Activity

Evommune (EVMN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.2% of shares outstanding. Institutional investors hold 24.1%.

Shares Outstanding

36.292M

Shares Float

24.518M

Insider Shares Owned

1.154M

Insider % Owned

3.2%

Institutional Shares Held

8.745M

Institutional % Held

24.1%

Ownership Breakdown

Net Insider Activity by Month

Evommune Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jul 8, 2026	Kyle Carver	CHIEF FINANCIAL OFFICER	BUY	1.000K	$13.26	$13K
Jul 7, 2026	ARTHUR KIRSCH	—	BUY	10.000K	$13.30	$133K
Jun 22, 2026	Suzann Janice Drew	CHIEF DEV. OPERATIONS	SELL-OPTIONS	—	$12.89	$390K
Jun 22, 2026	Pravinkumar Jeegar Patel	CHIEF SCIENTIFIC OFFICER	SELL-OPTIONS	—	$13.17	$28K
Jun 22, 2026	Luis Pena	PRESIDENT & CEO	SELL	7.438K	$22.71	$169K
Jun 2, 2026	David Cohen	—	SELL	6.056K	$20.33	$123K
Jun 1, 2026	Pravinkumar Jeegar Patel	CHIEF SCIENTIFIC OFFICER	SELL	3.175K	$13.29	$328K
Jun 1, 2026	Luis Pena	PRESIDENT & CEO	SELL	16.787K	$22.74	$382K
May 28, 2026	Gregory S Moss	CHIEF BUSINESS & LEGAL OFFICER	SELL-OPTIONS	—	$12.27	$300K
May 28, 2026	Kyle Carver	CHIEF FINANCIAL OFFICER	SELL	3.175K	$12.91	$370K